Abbott ABT Property, plant, and equipment additions

Property, plant, and equipment additions at other companies

LivaNovaLIVN

$23.66M+130%

Medical Devices$147M-5.8%

Diagnostic Products$128M-5.2%

Nutritional Products$40M-49.4%

Established Pharmaceuticals$20M-39.4%

Revenue$11.2B+7.8%

Gross profit$6.3B+6.5%

Operating income$1.3B-20.6%

Net income$1.1B-18.7%

EPS (diluted)$0.61-19.7%

Cash & equivalents$6.8B+4.1%

Total debt$34.0B+157%

Total equity$52.1B+6.7%

Total assets$110.43B+35.6%

Operating cash flow$1.3B-7.2%

CapEx$399.0M-17.6%

Free cash flow$916.0M-1.8%

Market cap$162.41B-29.8%

Enterprise value$189.65B-20.3%

P/E25.9×+8.7×

P/S3.6×-1.9×

Gross margin56.3%+0.4pp

Operating margin17.1%+0.2pp

Net margin13.9%-18.0pp

FCF margin16.3%+0.6pp

Return on equity12.4%-18.4pp

Debt / equity0.7×+0.4×

Current ratio1.4×-0.4×